Proton beam radiotherapy versus radiofrequency ablation treatment in patients with recurrent hepatocellular carcinoma: a randomized controlled phase 3 non-inferiority APROH trial
Joong‐Won Park(National Cancer Center), Boram Park, Tae Hyun Kim(Sookmyung Women's University), Min Ju Kim, Bo Hyun Kim, Ju‐Hee Lee(Dongguk University), Young-Hwan Koh(National Cancer Center)
Cited by 1
Related Papers
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
|International Journal of Radiation Oncology*Biology*Physics|2013|673